2021
DOI: 10.18231/j.ijmmtd.2021.039
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of various Beta-lactamases in Enterobacteriaceae in a tertiary care hospital in South India: A Cross-sectional study

Abstract: Antimicrobial resistance among bacteria has constantly increased over the years with emergence of novel resistance mechanism among these versatile organisms. Identifying the resistance pattern of the isolates both regionally and globally is essential for the institution of appropriate antimicrobial therapy. This study was conducted to assess the prevalence of beta-Lactamase enzymes among species of Enterobacteriaceae.312 consecutive isolates belonging to the family of Enterobacteriaceae were included in the st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Sample size was calculated based on the prevalence of ESBL among Enterobacteriaceae as reported by Kaup S et al (54.79%). 2 Total 170 strains of Enterobacteriaceae showing resistance to two or more classes of antimicrobials were further processed.…”
Section: Sample Sizementioning
confidence: 99%
See 2 more Smart Citations
“…Sample size was calculated based on the prevalence of ESBL among Enterobacteriaceae as reported by Kaup S et al (54.79%). 2 Total 170 strains of Enterobacteriaceae showing resistance to two or more classes of antimicrobials were further processed.…”
Section: Sample Sizementioning
confidence: 99%
“…1 The infections caused by MDR organisms are increasing gradually and pose a threat to treatment thereby leading to extended period of hospitalization, increased cost of health care and increased rate of morbidity and mortality. 2 Infections associated with ESBL producing organisms can be treated with third or fourth generation cephalosporins combined with clavulanic acid. 2 However, if organism is an Amp C enzyme producer along with ESBL, patient fails to respond to clavulanic acid combination.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation